Enzyme Developer EUCODIS Bioscience Launches Phospholipases

Thursday, March 11, 2010 General News J E 4
VIENNA, Austria, March 9, 2010 EUCODIS Bioscience, acompany providing customized enzymes to the pharmaceutical, chemical, andother industries, announced today that it has launched a panel ofphospholipases, adding a new enzyme family to its product portfolio.

Phospholipases are a group of enzymes that are widely used in theindustrial processing of natural fats and oils, such as in the food andbeverage industries, in the cosmetics industry, and in the manufacturing ofbioproducts from renewable resources (biomass). The market for phospholipasesis estimated at EUR 40 million.

In 2009, EUCODIS Bioscience has launched several enzyme products,including a library of currently 20 novel lipases and beta-lactamases.

Commenting on the launch of a new product group, Thomas Fischer, CEO ofEUCODIS Bioscience, said: "In adding new enzymes to our product portfolio, wecontinue to execute our customer-focused strategy: We offer novel enzymeswith promising properties to a broad range of industries, we manufacturecommercial quantities according to market demand, and we engineer enzymes tocustomers' specific needs. Feedback from the market is an impressiveconfirmation of this strategy, with our order book filling steadily."

About EUCODIS Bioscience

EUCODIS Bioscience GmbH develops, customizes, manufactures, and marketsindustrial enzymes.

EUCODIS Bioscience' products help customers in the chemical,pharmaceutical, and food and feed industries to make manufacturing processesmore efficient and cleaner, and to generate products with superior properties.

The Company offers a broad portfolio of novel enzymes, including lipases,phospholipases, and beta-lactamases.

Led by an experienced management team, EUCODIS Bioscience is backed byAustrian and German institutional venture capital funds and privateinvestors. The Company is headquartered in Austria, Europe, with a subsidiaryin Germany.For more information, please visit Company Contact EUCODIS Bioscience: Thomas Fischer, MBA CEO EUCODIS Bioscience Campus Vienna Biocenter II Viehmarktgasse 2 a/ 2. OG A-1030 Vienna AUSTRIA +43-1-8900804 or +43-676-3650016 Media Contact EUCODIS Bioscience: Frank Butschbacher Investor Relations & Communications +43-650-7844940



You May Also Like

View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
Announcing the Lumixyl(TM) Brightening System, a N...
Hard to Treat Diseases (HTDS) Collagenna Skin Care...